Please provide your email address to receive an email when new articles are posted on . Researchers produced an algorithm to standardize virtual myasthenia gravis assessments. More efforts are needed ...

Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

Myasthenia gravis and Lambert-Eaton syndrome both cause unusual muscle weakness but in different ways. In addition to slight differences in symptoms, they produce different diagnostic test results and ...

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

How Do Vyvgart & Vyvgart Hytrulo Work in gMG? gMG is an autoimmune disease where the immune system mistakenly damages the connections between your nerves and muscles. This weakens your muscles and ...

Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...

The FDA in April 2025 approved nipocalimab (Imaavy) as a treatment for people living with generalized myasthenia gravis (gMG). Specifically, nipocalimab is for people with gMG who are 12 and older and ...

Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...

A new retrospective analysis compared clinical features of White, Hispanic, and African-American patients with MG who visited a single university-based clinic. After adjusting for covariates, the ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...